SCHEMBL5809772

SCHEMBL5809772

CC(=NNC(=O)c1ccncc1)c1ccccc1O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.74
CYP3A4 P08684 2/20 0.73
SMN1; SMN2 Q16637 5/20 0.65
TP53 P04637 1/20 0.65
CYP1A2 P05177 1/20 0.65
CYP2C9 P11712 1/20 0.65
CYP2C19 P33261 1/20 0.65
BRCA1 P38398 1/20 0.65
HBB P68871 1/20 0.65
HIF1A Q16665 1/20 0.65
KDM4E B2RXH2 5/20 0.61
GAA P10253 4/20 0.60
MAPT P10636 4/20 0.58
HPGD P15428 1/20 0.58
HTT P42858 1/20 0.58
GSTA1 P08263 1/20 0.56
NPC1 O15118 5/20 0.56
RAB9A P51151 5/20 0.56
ALDH1A1 P00352 3/20 0.56
KMT2A Q03164 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5809768 1.00 KDM1A (0.74) KDM1ACYP3A4SMN1; SMN2TP53CYP1A2
SCHEMBL23719206 0.89 NPC1 (0.64) KDM1ACYP3A4SMN1; SMN2KDM4EGAA
SCHEMBL684658 0.88 KDM1A (0.83) KDM1ACYP3A4SMN1; SMN2CYP1A2CYP2C19
SCHEMBL19283326 0.85 KDM1A (1.00) KDM1ASMN1; SMN2KDM4EGAAMAPT
SCHEMBL14712657 0.85 KDM1A (1.00) KDM1ASMN1; SMN2KDM4EGAAMAPT
SCHEMBL23719208 0.85 KDM1A (1.00) KDM1ASMN1; SMN2KDM4EGAAMAPT
SCHEMBL684476 0.84 KDM1A (0.81) KDM1ACYP3A4SMN1; SMN2KDM4EGAA
SCHEMBL685157 0.84 KDM1A (0.81) KDM1ASMN1; SMN2CYP2C9KDM4EGAA
SCHEMBL28012829 0.84 KDM1A (0.81) KDM1ASMN1; SMN2CYP2C9KDM4EGAA
SCHEMBL5809221 0.84 GAA (0.62) KDM1ACYP3A4SMN1; SMN2TP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006136008-A1 SALICYLIC ACID HYDRAZONES AS INHIBITORS OF THE ERK MAPKINASE PATHWAY AND FOR THE TREATMENT OF CANCER UNIVERSITY HEALTH NETWORK (CA) 2006-12-28 WO disclosed